Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Rebif
Rebif Image


Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Rebif?

Rebif is a brand-name prescription medication that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing forms of multiple sclerosis (MS). MS is a chronic autoimmune disease in which the immune system mistakenly attacks the protective covering of nerve fibers in the central nervous system. Rebif is administered as an injectable medication and contains interferon beta-1a, which is a synthetic version of a protein naturally produced in the body. This drug works by modulating the immune system, reducing inflammation, and slowing down the progression of MS. By administering regular injections of Rebif, individuals with relapsing forms of MS can experience a reduction in the number and severity of flare-ups or relapses, as well as a decrease in the development of new lesions in the brain or spinal cord. It is important to note that Rebif is not a cure for MS, but it can help manage the disease and improve quality of life. It's important to follow the prescribed dosage and frequency of injections as instructed by your healthcare provider. Rebif may cause side effects such as injection site reactions, flu-like symptoms, liver problems, and depression. Monitoring and regular check-ups with your healthcare provider are necessary to ensure the drug's effectiveness and to address any potential side effects.

How to use Rebif?

When using Rebif, it's crucial to follow your healthcare provider's instructions carefully. Rebif is an FDA-approved prescription medication used to treat relapsing forms of multiple sclerosis (MS), a chronic autoimmune disease affecting the central nervous system. Rebif comes in the form of self-administered injections, and it's important to learn the proper technique from your healthcare provider. Typically, the medication is injected under the skin (subcutaneously) three times a week, with doses spread out evenly throughout the week. Before using Rebif, make sure to thoroughly clean the injection site with an alcohol swab and allow it to dry. Follow the specific instructions provided with the medication for preparing the injection and using the correct dosage. The injection is usually given in the thigh or stomach area, alternating the sites to prevent skin irritation. It's important to monitor for any adverse reactions or side effects after administration and report them to your healthcare provider. Common side effects may include flu-like symptoms such as fever, chills, muscle aches, and fatigue. These symptoms typically improve over time, but if they persist or worsen, it's important to contact your healthcare provider. Do not adjust your dosage or stop using Rebif without consulting your healthcare provider, as this medication is crucial for managing MS symptoms and preventing relapses. Your healthcare provider will determine the appropriate duration of treatment based on your individual condition. Always dispose of used needles and syringes in a designated sharps container to ensure proper disposal and prevent accidental needlestick injuries. If you have any questions or concerns about using Rebif, consult your healthcare provider for further guidance.

Rebif, as an FDA-approved treatment for relapsing forms of multiple sclerosis, carries several important warnings that patients should be aware of. These warnings aim to inform users about potential risks and help them make informed decisions in consultation with their healthcare provider. One significant warning associated with Rebif is the possibility of developing a serious and life-threatening condition called progressive multifocal leukoencephalopathy (PML). PML is caused by the activation of a dormant virus in the brain, and it can lead to severe disability or even death. Users of Rebif should be vigilant for unusual symptoms such as changes in vision, difficulty thinking or speaking, and weakness in the limbs, as these could be signs of PML. Another warning is the potential for liver damage. Rebif can cause an elevation in liver enzymes, which may be a sign of liver injury. Regular monitoring of liver function will be necessary during treatment to ensure the drug is not causing any harm. Additionally, there is a risk of depression and suicidal thoughts associated with Rebif usage. Patients and their caregivers should be alert for any changes in mood, behavior, or thoughts of self-harm while taking this medication, and immediate medical attention should be sought if any concerning symptoms arise. Rebif can also weaken the immune system, making users more susceptible to infections. It is essential to promptly report any signs of infection, such as fever, sore throat, or persistent cough, to a healthcare professional. These warnings are crucial for patients using Rebif to understand and discuss with their healthcare provider before starting the treatment. Close monitoring and regular communication with the healthcare team can ensure the safe and effective use of this medication.

Before taking Rebif, there are several important warnings and precautions that you should be aware of. It is crucial to discuss these with your healthcare provider before starting this medication. Here are the key points: 1. Allergic reactions: Some individuals may experience allergic reactions to Rebif. If you notice symptoms such as difficulty breathing, hives, or swelling of the face, lips, tongue, or throat, seek immediate medical attention. 2. Depression and suicidal thoughts: Rebif has been associated with depression and feelings of suicide in some patients. It is important to inform your doctor if you have a history of depression or if you experience any new or worsening symptoms of depression, such as feeling sad, hopeless, or having thoughts of self-harm. 3. Liver problems: Treatment with Rebif can cause liver problems, including an increase in liver enzymes and inflammation of the liver. Regular monitoring of liver function is necessary while on this medication. Inform your doctor if you have a history of liver disease before starting Rebif. 4. Blood disorders: Rebif can affect blood cell counts, leading to decreases in white blood cells, red blood cells, and platelets. Regular blood tests may be required to monitor these levels. 5. Injection site reactions: Common side effects of Rebif include injection site reactions, such as redness, swelling, pain, or swelling. Rotate injection sites as recommended by your healthcare provider to minimize discomfort. 6. Increased risk of infections: Rebif can suppress the immune system, increasing the risk of infections. Inform your doctor if you develop any signs of infection, such as fever, cough, or flu-like symptoms. Always follow your healthcare provider's instructions and report any side effects or concerns promptly. They will be able to provide more comprehensive information and guidance specific to your situation.

Rebif is a brand-name prescription medication used to treat relapsing forms of multiple sclerosis (MS). It is an injectable drug that helps to reduce the frequency and severity of MS relapses. However, like any medication, Rebif can have side effects. Some common side effects that may occur include flu-like symptoms such as fever, chills, muscle aches, and fatigue. These symptoms are usually mild and tend to diminish over time as the body adjusts to the medication. Other potential side effects include injection site reactions such as redness, swelling, or pain at the injection site. These reactions are usually temporary and can be managed with proper injection technique. Rebif may also impact liver function, so regular monitoring of liver enzymes is recommended while taking this medication. Less commonly, Rebif can cause more serious side effects such as depression or suicidal thoughts, severe allergic reactions, and changes in blood cell counts. It is important to contact a healthcare provider immediately if any of these more serious side effects occur. It's important to discuss all potential risks and benefits with a healthcare provider before starting Rebif or any medication. They can provide guidance based on individual health history and help manage any potential side effects that may arise.

The active ingredient in Rebif is interferon beta-1a, which is a natural protein produced by the body's immune system. It is a recombinant form of this protein, meaning it is created through genetic engineering. In addition to interferon beta-1a, Rebif contains other ingredients that help with its formulation and effectiveness. These ingredients include albumin (a protein found in blood plasma), mannitol (a sugar alcohol that acts as a stabilizer), and sodium chloride (commonly known as table salt). It's important to note that Rebif is administered as an injection, typically done under the skin (subcutaneously) or into the muscle (intramuscularly). It is available in different dosage strengths, and the exact formulation may vary depending on the specific dosage prescribed by the doctor. As with any medication, it is crucial to follow the prescribed dosage and administration instructions provided by the healthcare professional to ensure its safe and effective use in treating relapsing forms of multiple sclerosis (MS).

Rebif is a brand-name prescription injection used to treat relapsing forms of multiple sclerosis (MS), an autoimmune disease affecting the central nervous system. Proper storage of this medication is essential to maintain its effectiveness and safety. Here are the guidelines for storing Rebif: 1. Refrigeration: Rebif should be stored in the refrigerator between 36°F and 46°F (2°C and 8°C). Keep it in its original packaging and protect it from light. Do not freeze Rebif. 2. Room Temperature: If needed, Rebif can be stored at room temperature, between 77°F (25°C) and 86°F (30°C), for a maximum of 30 days. After 30 days, any unused medication should be discarded. 3. Avoid Heat and Sunlight: Rebif should be kept away from excessive heat and direct sunlight, as they can degrade the medication. 4. Out of Reach: Store Rebif away from the reach of children and pets. 5. Do Not Refreeze: If Rebif has been allowed to reach room temperature, do not refrigerate it again. Remember to check the expiration date and properly dispose of any expired or unused medication. If you have any specific storage-related concerns or questions, consult your healthcare provider or pharmacist for guidance.